<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName></PublisherName>
      <JournalTitle>IJOTM</JournalTitle>
      <Issn>2008-6490</Issn>
      <Volume>4</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>07</Month>
        <Day>11</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Isolation and Characterization of Human Mesenchymal Stem Cells Derived from Human Umbilical Cord Wharton’s Jelly and Amniotic Membrane</ArticleTitle>
    <FirstPage>111</FirstPage>
    <LastPage>116</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>T</FirstName>
        <LastName>Pirjali</LastName>
      </Author>
      <Author>
        <FirstName>N</FirstName>
        <LastName>Azarpira</LastName>
        <Affiliation>Transplant Research Center, Shiraz University of Medical Science, Shiraz, Iran. negarazarpira@yahoo.com</Affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Ayatollahi</LastName>
      </Author>
      <Author>
        <FirstName>MH</FirstName>
        <LastName>Aghdai</LastName>
      </Author>
      <Author>
        <FirstName>B</FirstName>
        <LastName>Geramizadeh</LastName>
      </Author>
      <Author>
        <FirstName>T</FirstName>
        <LastName>Talai</LastName>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2012</Year>
        <Month>11</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <Abstract>Background: Mesenchymal stem cells (MSCs) have a capacity for self-renewal and multi-potential differentiations. These cells are considered powerful sources for cell therapy in regenerative medicine and tissue engineering. The cells can be isolated from various tissues; however, harvesting from human umbilical cord and amniotic membrane is easy and accessible source.Objective: To isolate and characterize the MSCs derived from human umbilical cord Wharton&amp;rsquo;s jelly (WJMSC) and amniotic membrane (AM-MSC) with regard to their morphology, immunophenotype and mesodermal differentiation potential in order to obtain an alternative source of MSC for therapeutic clinical applications.Methods: Fetal membranes and umbilical cords (n=3) were retrieved from healthy full-term women by elective cesarean delivery. Amniotic membrane and umbilical cord were separately minced and cultured in DMEM supplemented with 10% FBS. After reaching 80% of confluency, the umbilical cord WJ-MSC and AM-MSC were characterized by expression of cell surface markers with flowcytometry, stem cell gene expression with adipogenic/osteogenic potential.Results: Both WJ-MSC and AM-MSC were spindle-shaped cells, expressed MSC surface markers in flowcytometry and stem cell transcriptional factors (OCT4 and NANOG). After induction, the cells differentiated into adipogenic and osteogenic lineages.Conclusion: MSC were successfully generated from umbilical cord WJ-MSC and AM-MSC with similar mesenchymal markers and properties.</Abstract>
  </Article>
</ArticleSet>
